| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $116.23 | $23.77 | 389.08% | 219.30x | 55.32x | 14.74x | 17.80x | 1.59x | $106.92M | 0.87% | $705.78M | 6.70 | $12.46B | 1,588.61 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $26.41 | $8.12 | 225.29% | 125.76x | 59.04x | 7.43x | 15.05x | 1.08x | $39.15M | 1.14% | $220.58M | 1.69 | $3.40B | 74.88 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $224.47 | $79.54 | 182.19% | 36.80x | 33.29x | 6.24x | 22.18x | 1.27x | $793.95M | 2.65% | $1.35B | 10.14 | $31.32B | 26.55 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $78.84 | $17.12 | 360.48% | 73.68x | 67.45x | 7.27x | 9.40x | 1.88x | $182.84M | 2.99% | $654.15M | 8.43 | $5.98B | 49.89 | ||
| RPRX | ROYALTY PHARMA PLC | $58.99 | $35.77 | 64.94% | 31.38x | 10.79x | 10.35x | 3.47x | 0.63x | $2.92B | 11.14% | $9.79B | 21.99 | $42.07B | 35.77 | ||
| VCEL | VERICEL CORP | $40.25 | $7.90 | 409.28% | 83.85x | 71.91x | 6.71x | 5.57x | 2.06x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 46.05 | ||
| KRYS | KRYSTAL BIOTECH INC | $330.69 | $83.00 | 298.42% | 39.99x | 42.37x | 22.17x | 7.20x | 2.14x | $257.78M | 2.64% | $1.36B | 46.03 | $9.37B | 40.16 | ||
| HALO | HALOZYME THERAPEUTICS INC | $116.82 | $70.34 | 66.07% | 32.81x | 12.93x | 8.23x | 92.37x | 0.63x | $806.22M | 5.89% | $143.54M | 1.22 | $15.24B | 21.21 | ||
| TGTX | TG THERAPEUTICS INC | $54.37 | $22.16 | 145.32% | 17.65x | 54.71x | 9.64x | 13.78x | 1.97x | $17.39M | 0.23% | $604.08M | 4.26 | $8.59B | 61.71 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.14 | $18.42 | 199.33% | 145.11x | 19.06x | 3.13x | 1.69x | 0.96x | $738.18M | 6.92% | $6.32B | 32.68 | $13.99B | 36.26 | ||
| ADMA | ADMA BIOLOGICS INC | $10.34 | $6.90 | 49.90% | 14.36x | 13.00x | 4.61x | 5.67x | 0.84x | $116.47M | 4.93% | $408.21M | 1.79 | $2.38B | 10.21 | ||
| EXEL | EXELIXIS INC | $60.99 | $29.66 | 105.62% | 18.54x | 18.44x | 6.28x | 8.20x | 1.22x | $1.17B | 7.67% | $1.84B | 7.35 | $15.00B | 13.79 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $209.65 | $178.21 | 17.64% | 13.74x | 8.20x | 2.88x | 2.83x | 0.56x | $1.62B | 12.22% | $4.80B | 75.98 | $16.38B | 10.14 | ||
| MDXG | MIMEDX GROUP INC | $4.70 | $1.26 | 273.44% | 117.50x | -27.10x | 1.96x | 3.17x | 1.28x | $44.50M | 6.40% | $216.00M | 1.46 | $566.44M | 24.83 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.23 | $7.52 | 35.97% | 10.77x | 9.40x | 4.45x | 2.79x | 0.94x | $82.01M | 13.55% | $217.65M | 3.68 | $463.67M | 6.00 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $294.99 | $84.87 | 247.58% | 29.29x | 31.23x | 20.37x | 6.08x | 2.22x | $130.62M | 2.21% | $967.52M | 48.22 | $6.01B | 21.53 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $498.50 | $146.67 | 239.88% | 28.77x | 26.04x | 10.05x | 6.24x | 2.16x | $3.80B | 3.00% | $20.25B | 79.81 | $122.18B | 22.20 | ||
| UTHR | UNITED THERAPEUTICS CORP | $540.03 | $186.47 | 189.61% | 17.86x | 20.21x | 7.29x | 3.62x | 3.28x | $1.09B | 4.75% | $6.40B | 150.24 | $21.36B | 12.74 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.51 | $29.75 | 26.09% | 11.95x | 9.00x | 2.26x | 2.19x | 0.71x | $354.90M | 16.33% | $999.24M | 17.25 | $1.79B | 6.39 | ||
| TECH | BIO-TECHNE CORP | $72.50 | $16.10 | 350.38% | 61.97x | 34.89x | 9.31x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.39B | 32.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $778.36 | $423.02 | 84.00% | 18.56x | 13.87x | 5.15x | 2.53x | 0.98x | $3.76B | 4.70% | $31.71B | 308.48 | $80.39B | 13.98 | ||
| VCYT | VERACYTE INC | $43.51 | $11.59 | 275.29% | 30.22x | 22.37x | 6.19x | 2.52x | 2.54x | $165.99M | 4.77% | $1.39B | 17.36 | $3.24B | 23.17 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.12 | $1.37 | -18.38% | 8.00x | -2.52x | 1.38x | 1.48x | 0.45x | $19.58M | 30.18% | $44.20M | 0.76 | $16.49M | 2.16 | ||
| INCY | INCYTE CORP | $111.57 | $58.24 | 91.58% | 13.74x | 31.47x | 3.84x | 3.56x | 1.54x | $1.92B | 8.59% | $6.34B | 31.66 | $18.66B | 9.03 |